Non‐disclosing preimplantation genetic diagnosis for Huntington disease

  title={Non‐disclosing preimplantation genetic diagnosis for Huntington disease},
  author={H J Stern and Gary L. Harton and Michael E. Sisson and Shirley L. Jones and Lee A. Fallon and Lilli P. Thorsell and Michael E. Getlinger and Susan H. Black and Joseph D. Schulman},
  journal={Prenatal Diagnosis},
Individuals at risk for Huntington disease face difficult decisions regarding their reproductive options. Most do not wish to pass on the gene for Huntington disease to their children, but may not be prepared themselves to undergo presymptomatic testing and learn their genetic status. For these reasons, many at‐risk individuals with a family history of HD would choose a method of genetic diagnosis that would assure them that they can have children unaffected with HD without revealing their own… 
Preimplantation genetic diagnosis for Huntington's disease with exclusion testing
The first PGD cycles for exclusion testing for Huntington's disease in five couples are described, three couples have had at least one PGD cycle so far and one pregnancy ensued and a healthy female baby was delivered.
Prenatal and Preimplantation Genetic Diagnosis of Huntington's Disease
Only a relatively few at-risk parents opt for PND and PGD, and compared to PND, PGD is even more seldom opted for as a reproductive option.
New tools for preimplantation genetic diagnosis of Huntington's disease and their clinical applications
12 multiplex fluorescent PCR protocols applied at the single-cell level for PGD, some of which target the CAG repeat while others use two different polymorphic microsatellites, as well as the characterisation and use of a new highly polymorphic intragenic marker.
Low utilization of prenatal and pre‐implantation genetic diagnosis in Huntington disease – risk discounting in preventive genetics
The decision‐making process regarding genetic testing in families with HD is examined and the possible reasons for the low uptake among this group are discussed.
Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres
It is concluded that PGD is a valuable and safe reproductive option for HD carriers and couples at risk of transmitting HD.
Molecular Genetic Analysis of Single Cells Fiorentino 269
Preimplantation genetic diagnosis has been introduced as an alternative to prenatal diagnosis to increase the options available for fertile couples who have a known genetically transmittable disease and has become an important complement to the presently available approaches for the prevention of genetic disorders and an established clinical option in reproductive medicine.
Current status of preimplantation diagnosis for single gene disorders.
Reproductive options for individuals at risk for transmission of a genetic disorder.
Current reproductive options, however, remain restricted to the prevention of transmitting an at-risk gene or genes, but do not include treatment or cure, and it is anticipated that this state of "halfway technology" will continue for years to come.
Preimplantation Genetic Diagnosis:
Recognition of the limitations of PGD, as well as ethical concerns regarding use and misuse of this technology, need to be considered by patients, clinicians, and policy makers.


Preimplantation genetic diagnosis for spinal muscular atrophy type I
PGT is possible for the deletions in the survival motor neuron (SMN) gene that have been identified in 98% of SMA type I cases and provides a means for couples at risk for spinal muscular atrophy type I to reduce their chance of initiating an affected pregnancy.
Preimplantation genetic testing for Huntington disease and certain other dominantly inherited disorders
Preimplantation genetic testing (PGT) on embryos from couples at risk for Huntington disease can achieve disease prevention in offspring without disclosure of parental genotype. This strategy may
Strategies for preimplantation genetic diagnosis of single gene disorders by DNA amplification
This paper sets out to review current protocols for the diagnosis of single gene defects in human preimplantation embryos, which depend on DNA amplification using PCR, subject to a vareity of pitfalls.
Preimplantation genetic testing for Marfan syndrome.
The world's first use of preimplantation genetic testing (PGT) to achieve a clinical pregnancy and live birth of a baby free of a Marfan mutation is reported.
Reliable gender screening for human preimplantation embryos, using multiple DNA target-sequences.
Dependable methods were developed for preimplantation sexing of human IVF embryos, for use in clinical settings where prospective parents are at high risk for transmission of X-linked diseases. Using
Huntington's disease
Your contributions to the investigation of this tragic disorder are presented and a review of current ideas about the disease is reviewed.
Single sperm analysis of the trinucleotide repeats in the Huntington's disease gene: quantification of the mutation frequency spectrum.
The CAG triplet repeat region of the Huntington's disease gene was amplified in 923 single sperm from three affected and two normal individuals and an excellent fit was found when the model specified that a random number of repeats are added during the progression of the polymerase through the repeated region.
A polymorphic DNA marker genetically linked to Huntington's disease
The chromosomal localization of the Huntington's disease gene is the first step in using recombinant DNA technology to identify the primary genetic defect in this disorder.